Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kerr Douglas
Chief Medical Officer at Dyne Therapeutics. Filing since 5 Mar 2025.
CIK 0001814189
Company
Date
Role
Action
Shares
Amount
Of holding
DYN
Dyne Therapeutics, Inc.
8 Sep 2026
Chief Medical Officer
Sold on a plan
1,290
$24.36K
0.8%
DYN
Dyne Therapeutics, Inc.
4 Sep 2026
Chief Medical Officer
Sold on a plan
3,745
$91.19K
2.2%
DYN
Dyne Therapeutics, Inc.
13 Aug 2026
Chief Medical Officer
Sold on a plan
1,556
$40.89K
0.9%
DYN
Dyne Therapeutics, Inc.
16 Jun 2026
Chief Medical Officer
Sold on a plan
887
$16.26K
0.5%
DYN
Dyne Therapeutics, Inc.
13 May 2026
Chief Medical Officer
Sold on a plan
1,564
$28.72K
0.9%
DYN
Dyne Therapeutics, Inc.
5 Mar 2026
Chief Medical Officer
Sold on a plan
904
$13.47K
0.5%
DYN
Dyne Therapeutics, Inc.
5 Dec 2025
Chief Medical Officer
Sold on a plan
880
$18.23K
1.0%
DYN
Dyne Therapeutics, Inc.
5 Sep 2025
Chief Medical Officer
Sold on a plan
873
$11.71K
1.0%
DYN
Dyne Therapeutics, Inc.
4 Sep 2025
Chief Medical Officer
Sold on a plan
3,552
$47.14K
3.8%
DYN
Dyne Therapeutics, Inc.
5 Jun 2025
Chief Medical Officer
Sold on a plan
1,342
$17.92K
1.4%
DYN
Dyne Therapeutics, Inc.
5 Mar 2025
Chief Medical Officer
Sold on a plan
1,343
$15.89K
1.4%
11 decisions on file.
